Evidence map›Paper›PMID 41281892›Full record

ArticleBioactive materials2026

Lymphatic incorporated biomimetic scaffold enhances Osteoangio-lymphogenic coupling via HIF-1α mediated mitochondrial reprogramming for osteoporotic bone repair.

Weipeng Sun, Qing Lin, Biyi Zhao, Minying Li, Jiacong Xiao, Xueshan Jin, Jinfu Liu, Yifei Wang, Ronghua Zhang, Xiaoyun Li and 1 more

Abstract read
In one paragraph

Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Weipeng SunState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, College of Traditional Chinese Medicine, Jinan University, No.601, West Huangpu Avenue, Tianhe District, Guangzhou, 510405, China.
Qing LinThe First Affiliated Hospital of Jinan University, No.613, West Huangpu Avenue, Tianhe District, Guangzhou, 510405, China.
Biyi ZhaoState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, College of Traditional Chinese Medicine, Jinan University, No.601, West Huangpu Avenue, Tianhe District, Guangzhou, 510405, China.
Minying LiSchool of Basic Medical Sciences, Guangzhou University of Chinese Medicine, No. 232, West Waihuan Road, Panyu District, Guangzhou Guangdong Province, 510006, China.
Jiacong XiaoFirst Clinical College, Guangzhou University of Chinese Medicine, No. 12, Ji Chang Road, Baiyun District, Guangzhou, 510000, Guangdong Province, China.
Xueshan JinState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, College of Traditional Chinese Medicine, Jinan University, No.601, West Huangpu Avenue, Tianhe District, Guangzhou, 510405, China.
Jinfu LiuState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, College of Traditional Chinese Medicine, Jinan University, No.601, West Huangpu Avenue, Tianhe District, Guangzhou, 510405, China.
Yifei WangAcupuncture and Rehabilitation Clinical Medicine Institute, Guangzhou University of Chinese Medicine, No. 232, West Waihuan Road, Panyu District, Guangzhou, 510006, Guangdong Province, China.
Ronghua ZhangState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, College of Traditional Chinese Medicine, Jinan University, No.601, West Huangpu Avenue, Tianhe District, Guangzhou, 510405, China.
Xiaoyun LiCollege of Pharmacy, Jinan University, Guangzhou, Guangdong Province, China.
Ziwei JiangDepartment of Orthopaedics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 12, Ji Chang Road, Baiyun District, Guangzhou, 510000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have challenged the notion that bone tissue lacks lymphatic vessels, highlighting their essential role in bone regeneration. Effective bone repair relies on the interplay of osteogenesis, angiogenesis, and lymphangiogenesis. Here, we present a three dimensional-printed biomimetic Gelatin methacryloyl/icariin@Mesoporous silica nanoparticle/Hydroxyapatite (GelMA/ICA@MSN/HAp) scaffold designed to recruit bone marrow mesenchymal stem cells (BMSCs), human umbilical vein endothelial cells (HUVECs), and lymphatic endothelial cells (LECs), enabling these cells to self-assemble into "cell islands" that coordinate tissue regeneration. The scaffold exhibits excellent biocompatibility, biodegradability, and sustained cytokine release. In vitro, it promotes the migration, proliferation, and lineage-specific differentiation of BMSCs, HUVECs, and LECs. In an osteoporotic bone defect model, the scaffold significantly enhances new bone formation, supports vascular remodeling by recruiting HUVECs, and induces lymphatic maturation via LECs, accompanied by upregulation of bone morphogenetic protein 2, vascular endothelial growth factor, and prospero homeobox protein 1. Transcriptomic analysis identifies activation of the hypoxia-inducible factor 1 alpha (HIF-1α) signaling pathway as crucial to these effects. Mechanistically, LECs-derived conditioned medium stimulates HUVECs angiogenesis and BMSCs osteogenesis by inducing HIF-1α mediated mitochondrial metabolic reprogramming. This is the first study to integrate lymphatic modulation into scaffold design for bone repair, achieving osteo-angio-lymphogenic coupling and establishing a novel organoid model for bone regeneration.

Indexed as

AngiogenesisBone repairComposite scaffoldLymphangiogenesisOsteogenesis

Identifiers

PMID41281892
PMCPMC12636390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.